Latest filing published 10 Oct 2019 for Aurinia Pharmaceuticals Inc., €5,813.
Filing timeline
BuySaleInsider track record
Rashieda Gluck: trading record in brief
Rashieda Gluck discloses dealings in Aurinia Pharmaceuticals Inc. to SEC (Form 4). In total, 29 filings cover trades dated from 4 January 2016 to 10 October 2019.
In open-market terms, that means 8 purchases worth €30k on one side and 11 sales worth €508k on the other. The net balance comes to €478k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 option exercises. So far in 2019, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €1,831. No cluster: in 8 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 10 October 2019: an open-market purchase of €5,813, in Aurinia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rashieda Gluck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ CA$4.25320.2% of flowCommon SharesTSXSEDI:3437343Canonical exit: 8 Jan 2020 (T+90)
- 4,500 shares@ CA$5.7159.0% of flowCommon SharesTSXSEDI:3251414
- 600 shares@ CA$5.677.8% of flowCommon SharesTSXSEDI:3251420
- 1,000 shares@ CA$5.6913.1% of flowCommon SharesTSXSEDI:3251419
- 700 shares@ CA$5.960.3% of flowCommon SharesTSXSEDI:3199695Canonical exit: 16 Sept 2018 (T+90)
- 3,800 shares@ CA$5.701.7% of flowCommon SharesTSXSEDI:3196379Canonical exit: 5 Sept 2018 (T+90)
- 1,483 shares@ CA$2.770.3% of flowCommon SharesTSXSEDI:3196376
- Common SharesTSXSEDI:3196382
- Common SharesTSXSEDI:3196377
- 40,000 shares@ CA$3.3910.8% of flowCommon SharesTSXSEDI:3185766
- 22,500 shares@ CA$4.217.5% of flowCommon SharesTSXSEDI:3185768
- 101,200 shares@ CA$6.0948.9% of flowCommon SharesTSXSEDI:3185769
- 25,000 shares@ CA$5.1910.3% of flowCommon SharesTSXSEDI:3185765
- 23,000 shares@ CA$3.957.2% of flowCommon SharesTSXSEDI:3185767
- 4,500 shares@ CA$5.301.8% of flowCommon SharesTSXSEDI:3185764
- 1,000 shares@ CA$5.290.4% of flowCommon SharesTSXSEDI:3185763
- 9,300 shares@ CA$6.0784.5% of flowCommon SharesTSXSEDI:3185770
- 500 shares@ CA$5.280.2% of flowCommon SharesTSXSEDI:3128032Canonical exit: 1 May 2018 (T+90)
- 500 shares@ CA$5.520.2% of flowCommon SharesTSXSEDI:3128031Canonical exit: 30 Apr 2018 (T+90)
- 263 shares@ CA$5.140.1% of flowCommon SharesTSXSEDI:3089073Canonical exit: 27 Feb 2018 (T+90)
- 2,000 shares@ CA$7.081.1% of flowCommon SharesTSXSEDI:3038748
- 3,000 shares@ CA$2.9450.7% of flowCommon SharesTSXSEDI:2949076
- 1,500 shares@ CA$3.030.4% of flowCommon SharesTSXSEDI:2870428
- 4,237 shares@ CA$2.360.8% of flowCommon SharesTSXSEDI:2855155
- 1,500 shares@ CA$3.000.4% of flowCommon SharesTSXSEDI:2812913
25 of 29 declarations
